Search Result "NVP-DPP728"
11 Years of Cyanopyrrolidines as DPP-IV Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 6 Year: 2007 Page: 579-595
Author(s): Jens-Uwe Peters
Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
Journal: Current Drug Targets
Volume: 15 Issue: 6 Year: 2014 Page: 600-621
Author(s): Sridhara Janardhan,G. Narahari Sastry
Inhibitors of Dipeptidyl Peptidase IV - Recent Advances and Structural Views
Journal: Current Topics in Medicinal Chemistry
Volume: 5 Issue: 1 Year: 2005 Page: 1623-1637
Author(s): Daniel Hunziker, Michael Hennig, Jens-Uwe Peters
Inhibition of Dipeptidyl Peptidase-4 (DPP-4) - A Novel Approach to Treat Type 2 Diabetes
Journal: Current Enzyme Inhibition
Volume: 1 Issue: 1 Year: 2005 Page: 65-73
Author(s): Bo Ahren
Advances in Antidiabetic Drugs Targeting Insulin Secretion
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 34 Year: 2018 Page: 3990-3997
Author(s): Yanting Ding,Yilian Li,Qin Chen,Bing Niu
Molecular Recognition of Ligands in Dipeptidyl Peptidase IV
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 6 Year: 2007 Page: 609-620
Author(s): Bernd Kuhn, Michael Hennig, Patrizio Mattei
Discovery of JANUVIA TM (Sitagliptin), a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type2 Diabetes.
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 6 Year: 2007 Page: 557-568
Author(s): Nancy A. Thornberry, Ann E. Weber
Dipeptidyl Peptidase IV Inhibitors: The Next Generation of New Promising Therapies for the Management of Type 2 Diabetes
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 6 Year: 2007 Page: 547-555
Author(s): Elena Sebokova, Andreas D. Christ, Markus Boehringer, Jacques Mizrahi
CD26 / Dipeptidyl Peptidase IV: A Regulator of Immune Function and a Potential Molecular Target for Therapy
Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 4 Issue: 1 Year: 2004 Page: 11-18
Author(s): Ugur Aytac, Nam H. Dang
CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune Disorders
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7 Issue: 3 Year: 2007 Page: 253-273
Author(s): Michael A. Thompson, Kei Ohnuma, Masako Abe, Chikao Morimoto, Nam H. Dang